Login/Sign Up
₹19125*
MRP ₹21250
10% off
₹19125*
MRP ₹21250
10% CB
₹2125 cashback(10%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Erbitux 5mg/ml Injection is used with or without radiation therapy to treat various cancer conditions, such as metastatic cancer of the large intestine and squamous cell cancer (a specific type of head and neck cancer). It contains Cetuximab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading. The most common side effects are inflammation of the lining of the intestine, mouth, and nose, nose bleeding, headache, tiredness, irritation and redness of the eye, diarrhoea, feeling sick, vomiting, loss of appetite, and weight loss.
Provide Delivery Location
Whats That
About Erbitux 5mg/ml Injection
Erbitux 5mg/ml Injection belongs to a class of monoclonal antibodies. It is used with or without radiation therapy to treat various cancer conditions, such as metastatic cancer of the large intestine and squamous cell cancer (a certain type of head and neck cancer). Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues.
Erbitux 5mg/ml Injection contains Cetuximab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading.
Erbitux 5mg/ml Injection will be administered by a qualified healthcare professional who is experienced in the administration of chemotherapeutic agents. The most common side effects are inflammation of the lining of the intestine, mouth, and nose, nose bleeding, headache, tiredness, irritation and redness of the eye, diarrhoea, feeling sick, vomiting, loss of appetite, and weight loss. Talk to your doctor if any of these side effects persist or worsen.
It is recommended not to use if you are allergic to any ingredient in Erbitux 5mg/ml Injection. Erbitux 5mg/ml Injection may cause foetal harm when administered to a pregnant woman. It is critical not to become pregnant while undergoing therapy and for several months after the treatment. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner becomes pregnant while undergoing therapy. Do not breastfeed your baby while on treatment with Cetuximab and for two months after the last dose. Alcohol should be avoided during treatment with this medicine. Drive only if you are alert, as the Erbitux 5mg/ml Injection may cause you to feel sick or tired.
If you have head and neck cancer and are treated with radiation therapy with cetuximab, you may be at an elevated risk of cardiopulmonary arrest (when the heart stops beating and respiration stops) and sudden death during or after treatment. Inform your doctor if you have or have ever had coronary artery disease (a condition in which the blood vessels of the heart narrow or become clogged by fat or cholesterol deposits); heart failure (a condition in which the heart is unable to pump enough blood to the rest of the body); irregular heartbeat; other heart disease; or lower than normal levels of magnesium, potassium, or calcium in your blood.
Uses of Erbitux 5mg/ml Injection
Directions for Use
Medicinal Benefits
Erbitux 5mg/ml Injection is a monoclonal antibody. It is used alone or in combination with other anticancer medications to treat various cancer diseases, including metastatic cancer of the large intestine and squamous cell cancer (a form of head and neck cancer). Cetuximab is present in Erbitux 5mg/ml Injection and works by slowing or preventing the growth of cancer cells. As a result, it inhibits the cancer from spreading.
How Erbitux 5mg/ml Injection Works
Storage
What if I have taken an overdose of Erbitux 5mg/ml Injection
Drug Warnings
Before taking Erbitux 5mg/ml Injection, inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. It's crucial to take your medication as directed. The dosage of this medicine is based on your condition. Your doctor may adjust your dose during therapy based on the treatment results. Consult a doctor immediately if you suffer any symptoms, especially if you also have a cough or fever, such as the onset or worsening of breathing problems. If therapy needs to be stopped, your doctor will make that decision. Erbitux 5mg/ml Injection is recommended not to be used in pregnant women or nursing mothers; if you become pregnant while on treatment with Cetuximab, tell your doctor right away.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Erbitux 5mg/ml Injection as it may cause serious side effects.
Pregnancy
Unsafe
Erbitux 5mg/ml Injection is not recommended for use during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while on treatment with Erbitux 5mg/ml Injection.
Breast Feeding
Unsafe
Do not breastfeed your baby when you are being treated with Erbitux 5mg/ml Injection and for two months after the last dose.
Driving
Caution
Drive only if alert, as the Erbitux 5mg/ml Injection may cause feeling sick or tiredness.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Erbitux 5mg/ml Injection. Your doctor will weigh the benefits and potential risks before prescribing this medicine.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before taking Erbitux 5mg/ml Injection. Your doctor may titrate the dose if required based on your condition.
Children
Safe if prescribed
Erbitux 5mg/ml Injection can be used to treat certain cancers in children. Please consult your doctor for more information.
Have a query?
Erbitux 5mg/ml Injection is used to treat Cancer.
Erbitux 5mg/ml Injection contains Cetuximab, which works by slowing or stopping the growth of cancer cells. Thereby, it prevents the cancer from spreading.
Attend all your doctor's appointments while taking Erbitux 5mg/ml Injection to ensure the therapy is effective. Regular blood tests and weight checks must be performed. While taking the Erbitux 5mg/ml Injection, both men and women should use an effective means of contraception. Do not use any other medications unless prescribed by the doctor. If you have low levels of Magnesium and Calcium in your blood, inform your doctor before treating you with this medicine.
Do not stop taking Erbitux 5mg/ml Injection on your own. Take Erbitux 5mg/ml Injection for as long as your doctor prescribes it, depending on your medical condition. Do not miss any scheduled dose. Speak with your doctor if you experience difficulty using Erbitux 5mg/ml Injection.
Some dietary changes can help you manage side effects; for example, in case of diarrhoea-Choose foods or drinks with sodium (sports drinks or broth) and potassium (bananas and all-natural fruit juices).
Yes, Erbitux 5mg/ml Injection is a chemotherapy drug, but it is specifically classified as a monoclonal antibody. It works by targeting and blocking the epidermal growth factor receptor (EGFR) on cancer cells, which helps slow or stop tumour growth. It is used primarily for the treatment of certain types of cancers, such as colorectal cancer and head and neck cancers.
Erbitux 5mg/ml Injection is a monoclonal antibody used to treat cancer. It is neither a cytotoxic agent nor a vesicant, but it acts as a radio sensitizer by enhancing the effects of radiation therapy on cancer cells.
Erbitux 5mg/ml Injection is administered through intravenous infusion by the doctor or nurse. The infusion is typically given over a period of time, with the rate depending on the patient's tolerance and the treatment plan. Do not self-administer.
Yes, Erbitux 5mg/ml Injection may cause hair loss as a common side effect. If you experience this symptom, manage stress, use gentle hair care practices, and eat nutritious food. However, if hair loss persists consult the doctor for further guidance.
Erbitux 5mg/ml Injection may cause a rash as a side effect because it targets and blocks the epidermal growth factor receptor (EGFR), which plays a key role in skin cell growth and repair. Inhibiting EGFR can lead to skin inflammation and reactions, resulting in the rash. However, consult the doctor if this symptom persists or worsens.
The duration of a rash depends on its cause. Some rashes may last for only a few days, while others can persist for weeks or even months. If the rash persists or worsens, consult the doctor for proper diagnosis and treatment.
The side effects of Erbitux 5mg/ml Injection include headache, inflammation of the lining of the intestine, mouth, and nose, nose bleeding, tiredness, irritation and redness of the eye, diarrhoea, feeling sick, vomiting, loss of appetite, and weight loss. Consult the doctor if any of these symptoms persist or worsen.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information